Peptides on the FDA Hot Seat
The FDA’s upcoming meeting could jeopardize access to essential natural ingredients used in compounded medicines, threatening personalized healthcare and patient freedom. Action Alert! Listen to the audio version of this article: THE TOPLINE On October 29th, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) will meet to discuss whether several key ingredients, including kisspeptin-10 and l-theanine, […]